by Marilyn | May 8, 2018 | Uncategorized
“I am going to tell you about my current hypothesis and working model—I welcome your comments and criticisms. Models are meant to be broken”. That is how a well respected researcher from a top academic institution began his seminar. He certainly got my attention. The...
by Marilyn | Apr 2, 2018 | Uncategorized
William Ury, coauthor of the well known negotiation book “Getting to Yes”, recently popularized the notion of the Third Side. In a conflict, the Third Side are those who are part of the larger group, community, or organization that support the essential needs of...
by Marilyn | Jan 25, 2016 | Uncategorized
Over the years, I have prepared a lot of disease summaries that include things like current standard treatments, drugs in development, and unmet needs. We typically think of unmet needs in clinical terms; limiting or stopping disease progression, alleviating...
by Marilyn | Jan 18, 2016 | Uncategorized
This is always a reflective time with the New Year and the close of another JP Morgan Healthcare Conference. In between reading all the blogs and updates from JPM, I read a couple of interesting and very timely articles in the Harvard Business Review. Both of these...
by Marilyn | Oct 5, 2015 | Uncategorized
I recently climbed La Plata, a 14000 + foot mountain in Colorado, (fondly known as a 14er). The experience reminded me of important lessons in risk analysis and decision making. If you are in a hurry for the lessons, you can go to the end. Years ago, I lived in...
by Marilyn | Jan 26, 2015 | Uncategorized
I am not one to make New Year’s resolutions, but like a lot of people, I find the beginning of the year a time of hope and optimism. There has been a lot of recent news, both positive and negative, from the life sciences industry. I see opportunities. Why We Do What...
